These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 176961)

  • 1. Cyclic adenosinemonophosphate in cerebrospinal fluid. Effects of theophylline, L-dopa and a dopamine receptor stimulant in rats.
    Kiessling M; Lindl T; Cramer H
    Arch Psychiatr Nervenkr (1970); 1975 Dec; 220(4):325-33. PubMed ID: 176961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of levodopa and piribedil on cyclic AMP levels in cerebrospinal fluid in rats (author's transl)].
    Cramer H; Kiessling M
    Arzneimittelforschung; 1976; 26(6):1106-7. PubMed ID: 183794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of dopamine biosynthesis by l-DOPA in PC12 cells: implications of L-DOPA influx and cyclic AMP.
    Jin CM; Yang YJ; Huang HS; Lim SC; Kai M; Lee MK
    Eur J Pharmacol; 2008 Sep; 591(1-3):88-95. PubMed ID: 18602388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Locomotor stimulation by L-dopa: relative importance of noradrenaline receptor activation.
    Andén NE; Strömbom U; Svensson TH
    Psychopharmacology (Berl); 1977 Nov; 54(3):243-8. PubMed ID: 413140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. L-Dopa and piribedil alter different components of attentional behavior dependent on dose.
    Cheal M
    Psychopharmacology (Berl); 1983; 80(4):345-50. PubMed ID: 6414004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine and L-dopa: inhibition of thyrotropin-stimulated thyroidal thyroxine release.
    Maayan ML; Sellitto RV; Volpert EM
    Endocrinology; 1986 Feb; 118(2):632-6. PubMed ID: 2867890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noradrenaline synthesis from L-DOPA in rodents and its relationship to motor activity.
    Dolphin A; Jenner P; Marsden CD
    Pharmacol Biochem Behav; 1976 Oct; 5(4):431-9. PubMed ID: 1005491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proceedings: The mechanism of the effect of dopamine-beta-hydroxylase inhibitor FLA-63 on the L-DOPA reversal of reserpine akinesia.
    Dolphin A; Jenner P; Marsden CD
    Br J Pharmacol; 1975 Jun; 54(2):246P-247P. PubMed ID: 1148534
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of L-dopa and propranolol on human CSF cyclic nucleotides.
    Belmaker RH; Ebstein RP; Biederman J; Stern R; Berman M; van Praag HM
    Psychopharmacology (Berl); 1978 Jul; 58(3):307-10. PubMed ID: 210480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mediation of enhanced reflex vagal bradycardia by L-dopa via central dopamine formation in dogs.
    Antonaccio MJ; Kerwin L
    Arch Int Pharmacodyn Ther; 1977 Mar; 226(1):56-68. PubMed ID: 869641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modification of the L-DOPA reversal of reserpine akinesia by inhibitors of dopamine-beta-hydroxylase.
    Dolphin A; Jenner P; Marsden CD
    Eur J Pharmacol; 1976 Jan; 35(1):135-44. PubMed ID: 1253815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of L-dopa on peripheral sympathetic nerve function: role of presynaptic dopamine receptors.
    Lokhandwala MF; Buckley JP
    J Pharmacol Exp Ther; 1978 Feb; 204(2):362-71. PubMed ID: 621670
    [No Abstract]   [Full Text] [Related]  

  • 13. Noradrenaline but not dopamine involved in NMDA receptor-mediated hyperalgesia induced by theophylline in awake rats.
    Paalzow GH
    Eur J Pharmacol; 1994 Jan; 252(1):87-97. PubMed ID: 7908645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the role of the central noradrenergic and dopaminergic systems in the regulation of TSH secretion in the rat.
    Krulich L; Giachetti A; Marchlewska-Koj A; Hefco E; Jameson HE
    Endocrinology; 1977 Feb; 100(2):496-505. PubMed ID: 188629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of PC12 cell viability by forskolin-induced cyclic AMP levels through ERK and JNK pathways: an implication for L-DOPA-induced cytotoxicity in nigrostriatal dopamine neurons.
    Park KH; Park HJ; Shin KS; Choi HS; Kai M; Lee MK
    Toxicol Sci; 2012 Jul; 128(1):247-57. PubMed ID: 22539619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. β-asarone and levodopa coadministration increases striatal levels of dopamine and levodopa and improves behavioral competence in Parkinson's rat by enhancing dopa decarboxylase activity.
    Huang L; Deng M; Zhang S; Lu S; Gui X; Fang Y
    Biomed Pharmacother; 2017 Oct; 94():666-678. PubMed ID: 28787702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of piribedil (ET495) on components of locomotor activity.
    Jenner P; Marsden CD
    Eur J Pharmacol; 1975 Aug; 33(1):211-5. PubMed ID: 1175688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the mechanism of hyperglycemia and stimulation of growth hormone secretion by L-dopa.
    Hampshire J; Moraru E; Altszuler N
    Pharmacology; 1978; 17(3):138-48. PubMed ID: 704657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Centrally mediated increased reflex vagal bradycardia after L-dopa in monoamine oxidase-inhibited anesthetized dogs.
    Antonaccio MJ; Kerwin L
    J Pharmacol Exp Ther; 1976 Feb; 196(2):380-8. PubMed ID: 1255483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual effects of L-3,4-dihydroxyphenylalanine on aromatic L-amino acid decarboxylase, dopamine release and motor stimulation in the reserpine-treated rat: evidence that behaviour is dopamine independent.
    Fisher A; Biggs CS; Eradiri O; Starr MS
    Neuroscience; 2000; 95(1):97-111. PubMed ID: 10619466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.